A new antibiotic that Advanced Life Sciences Holdings Inc. hopes to bring to market was shown to be safe and effective in treating pneumonia, the company will report Thursday. The antibiotic, cethromycin, also has shown in test tube experiments that it can fight MRSA, the so-called superbug staph infection that has caused worries because of its drug resistance. » Click here to read more...

Northwestern University will present a series of free, public events as an opportunity to learn more about this field.  The Nanotechnology Town Hall Meetings will focus on a basic introduction to the fundamentals of nanoscale science and an open discussion of the potential applications and ethical implications of this evolving field.  » Click here to read more...

iBIO has joined the IVCA and others to make the 2008 Midwest Venture Summit the most succesful ever.
A limited number of Full Event Sponsorships are available. Sponsors gain brand exposure and communicate their Midwest leadership positions to MVS attendees over 4 months through a powerful combination of e-marketing campaigns, print advertising, on-site material distribution and signage, and program exposure. Early sponsorship commitment leads to exposure in all outbound and online marketing materials. Take advantage of our 13 state "Greater Midwest" marketing initiative today. » Click here to read more...

ALSO:
How can you pitch your business plan to multiple VCs and Angels at one time?

Opportunities are available for companies in various stages of growth, from early* to series A+** who are located in the 13 state "Greater Midwest". Prior year MVS presenting companies have received over $222 million in VC funding to date. If you want to land on the pulse of technology business and financing in the Midwest you cannot miss the 2008 Midwest Venture Capital Summit. » Click here to read more...

Minuscule particles engineered to cause human cells to make their own medicines, regenerate damaged organs and even send up flares to let researchers know each time they kill a cancer cell are already working in labs and poised for commercialization in a few years. » Click here to read more...